Economics at your fingertips  

Deficit Syndrome of Schizophrenia - Assuaging by Norepinephrine Reuptake Inhibitor

Saeed Shoja Shafti, Mohammad Sadeghe Jafarabad and Reza Azizi
Additional contact information
Saeed Shoja Shafti: Professor of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Razi Psychiatric Hospital, Tehran, Iran
Mohammad Sadeghe Jafarabad: Psychiatrist, Razi Psychiatric Hospital, Iran
Reza Azizi: General physician, Razi Psychiatric Hospital, Iran

Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 3, 13631-13636

Abstract: Despite advances made in treating the positive symptoms of schizophrenia, treatment of negative symptoms remains an unmet therapeutic need...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Schizophrenia; Negative Symptom; Reboxetine (search for similar items in EconPapers)
JEL-codes: R00 Z0 (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link) (application/pdf) (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

DOI: 10.26717/BJSTR.2019.18.003162

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().

Page updated 2019-09-10
Handle: RePEc:abf:journl:v:18:y:2019:i:3:p:13631-13636